About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lung Cancer Clinical Trials in Portland | 392 Studies

Clinical Trials Lung CancerPortland

Lung Cancer Clinical Trials in Portland

Find 392 clinical trials for lung cancer near Portland, Oregon. Connect with research centers in your area.

All Lung Cancer trials nationwide All trials in Portland

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 21-40 of 392 trials

RecruitingA Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)Researchers are looking for a better way to treat people who have advanced non-small cell lung cancer (NSCLC) with specific genetic changes called human epidermal growth factor…NCT06452277·Newport Beach, California and 278 others

Lung Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

Active not recruitingFc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced CancerThis study is an open-label, Phase 1, multicenter study to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamic (PD) profiles of a novel fragment…NCT03860272·Scottsdale, Arizona and 17 others

TerminatedSurgery With or Without Internal Radiation Therapy Compared With Stereotactic Body Radiation Therapy in Treating Patients With High-Risk Stage I Non-Small Cell Lung CancerRATIONALE: Surgery with or without internal radiation therapy may be an effective treatment for non-small cell lung cancer.NCT01336894·Birmingham, Alabama and 52 others

TerminatedA Study to Investigate LYL797 in Adults With Solid TumorsThis study will evaluate the safety and tolerability of LYL797, a ROR1-targeted CAR T-cell therapy, in patients with ROR1+ relapsed or refractory triple negative breast cancer…NCT05274451·Scottsdale, Arizona and 17 others

CompletedGemcitabine or Gemcitabine Plus Docetaxel After Cisplatin, Etoposide and Radiation in Non Small Cell Lung Cancer (NSCLC)To assess the 2 year survival of patients with Stage III unresectable non-small cell lung cancer receiving consolidation gemcitabine or gemcitabine plus docetaxel following…NCT00191139·Denver, Colorado and 14 others

Active not recruitingGEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid TumorsThe goal of this trial is to learn about the antibody GEN1042 when it is used alone and when it is used together with another antibody cancer drug, pembrolizumab (with or without…NCT04083599·Anchorage, Alaska and 75 others

CompletedA Double-blind Study Evaluating IPI-504 and Docetaxel in Patients With Non-Small Cell Lung CancerThe purpose of this study is to compare the impact of IPI-504 in combination with docetaxel to placebo in combination with docetaxel on life expectancy in patients with Non Small…NCT01362400·Chandler, Arizona and 64 others

RecruitingStudy of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)A Study of Izalontamab Brengitecan (BMS-986507) versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer after failure of EGFR TKI TherapyNCT07100080·Irvine, California and 184 others

CompletedPhase I/II Eval Safety & Prelim Activity Nivolumab Comb W/Vorolanib Pts W/Refractory Thoracic TumorsThis is a two-agent, open-label, non-randomized, Phase 1/2 dose escalation and dose expansion study of combinatorial oral vorolanib plus infusional nivolumab in patients with…NCT03583086·Palo Alto, California and 6 others

CompletedCarboplatin and Paclitaxel Combined With Cetuximab and/or IMC-A12 in Patients With Advanced Non-Small Cell Lung CancerThis randomized phase II trial is studying how well giving carboplatin and paclitaxel together with cetuximab and/or cixutumumab (IMC-A12) works in treating patients with stage…NCT00986674·Stanford, California and 248 others

CompletedA Study to Evaluate Bevacizumab and Chemotherapy or Tarceva in Treating Recurrent or Refractory NSCLC (Non-Small Cell Lung Cancer)This Phase II, multicenter, randomized trial is designed to make preliminary evaluations of the efficacy of combining bevacizumab with chemotherapy (docetaxel or pemetrexed) or…NCT00095225·Bakersfield, California and 47 others

TerminatedDurvalumab Followed by Chemoradiation and Consolidation Durvalumab for Stage III Non-small Cell Lung CancerSingle arm study of induction durvalumab (1500 mg IV) for 1 cycle (every 4 weeks), administered prior to starting concurrent definitive chemoradiation, followed by consolidation…NCT04364048·Chicago, Illinois and 4 others

TerminatedStudy of Inlexisertib (DCC-3116) in Participants With RAS/MAPK Pathway Mutant Solid TumorsThis is a multicenter, open label, first in human (FIH) study of inlexisertib as monotherapy, and in combination with trametinib, binimetinib, or sotorasib in participants with…NCT04892017·Boston, Massachusetts and 9 others

CompletedA Study of CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1The main purpose of this study is to examine the safety and tolerability of CDX-1401 when given in combination with an immune stimulant (resiquimod) to patients with advanced…NCT00948961·New Haven, Connecticut and 6 others

CompletedA Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung CancerA Phase 1-2 study of MM-121 in combination with standard therapy for non-small cell lung cancer (NSCLC).NCT00994123·Birmingham, Alabama and 37 others

CompletedA Study of TAK-676 With Pembrolizumab After Radiation Therapy to Treat a Number of CancersIn this study, adults with non-small-cell lung cancer (NSCLC), triple-negative breast cancer (TNBC) and squamous-cell carcinoma of the head and neck (SCCHN) will be treated with…NCT04879849·Duarte, California and 4 others

CompletedStereotactic Body Radiation Therapy in Treating Patients With Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate CancerThis phase I trial studies the side effects and the best dose of stereotactic body radiation therapy in treating patients with breast cancer, non-small cell lung cancer, or…NCT02206334·Birmingham, Alabama and 77 others

Active not recruitingPhase I Study of Autologous CD8+ and CD4+ Engineered T Cell Receptor T Cells in Subjects With Advanced or Metastatic Solid TumorThis study is open to adult patients with solid tumors who have a KRAS G12V mutation.NCT06105021·Los Angeles, California and 9 others

CompletedSelumetinib and Paclitaxel as Second-Line Treatment in Treating Patients With Stage IIIB-IV Non-small Cell Lung CancerThis randomized phase I trial is studying the side effects and the best dose of selumetinib when given together with paclitaxel as a second line therapy in treating patients with…NCT02503358·Portland, Oregon

CompletedAn Open-label Study of GSK1120212 Compared With Docetaxel in Stage IV KRAS-mutant Non-small Cell Lung CancerThis is a phase II, open-label, multicenter, randomized study to evaluate the efficacy and safety of GSK1120212 compared with docetaxel in the second line setting for subjects…NCT01362296·Scottsdale, Arizona and 59 others

PreviousPage 2 of 20Next

Other Conditions in Portland

Breast Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma